Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the world's most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. Chemically patterned microchips enable real-time, non-invasive monitoring of organ function where we use sophisticated measurement techniques to detect minute changes.
This breakthrough technology enables unprecedented visibility into specific disease states and how the human body will respond to treatment - something that previously required costly animal testing and human trials to determine. The functional, interconnected, human in vitro platform, provides preclinical insight into the efficacy and toxicity of novel therapeutics.
Ultimately, Hesperos’ Human-on-a-Chip is reducing the need for animal testing in drug discovery while enabling research into rare diseases previously considered untreatable.
Company Details
- Employees
- 61
- Founded
- -
- Address
- 3259 Progress Dr, Orlando,florida 32826,united States
- Industry
- Biotechnology
- Website
- hesperosinc.com
- HQ
- Orlando, Florida
Hesperos Inc. Questions
Hesperos Inc.'s website is hesperosinc.com
Hesperos Inc.'s LinkedIn profile is https://www.linkedin.com/company/hesperos-inc.
Hesperos Inc. has
61 employees.
View email and phone details for 61
employees at Hesperos Inc..
Hesperos Inc.'s industry is
Biotechnology
Hesperos Inc.'s top competitors are
Axosim,
Insphero,
Cn Bio,
Mimetas,
Tissuse Gmbh,
Netri,
Alveolix,
Emulate, Inc.,
4dcell,
Cherry Biotech.
Hesperos Inc.'s categories are Biotechnology
Hesperos Inc.'s founding year is 2015
